Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 14/20 | 0.50 |
| ▸ | MAOB | P27338 | 3/20 | 0.41 |
| ▸ | MAOA | P21397 | 2/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7600364 | 0.85 | TACR1 (0.46) | TACR1MAOBMAOACYP19A1 | |
| SCHEMBL9507193 | 0.84 | MAOB (0.41) | TACR1MAOBMAOACYP19A1TP53 | |
| SCHEMBL9066577 | 0.81 | TACR1 (0.57) | TACR1 | |
| SCHEMBL3621494 | 0.81 | TACR1 (0.57) | TACR1 | |
| SCHEMBL4088856 | 0.81 | TACR1 (0.57) | TACR1 | |
| SCHEMBL8011823 | 0.79 | CYP3A4 (0.50) | MAOBMAOACYP19A1TP53CYP3A4 | |
| SCHEMBL6252491 | 0.79 | ADRB2 (0.44) | TACR1MAOBMAOACYP19A1 | |
| SCHEMBL6255049 | 0.79 | ADRB2 (0.44) | TACR1MAOBMAOACYP19A1 | |
| SCHEMBL366865 | 0.78 | MAOB (0.56) | MAOBMAOACYP19A1TP53CYP3A4 | |
| SCHEMBL2171476 | 0.78 | MAOA (0.47) | MAOBMAOACYP19A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1214288-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE | Targacept Inc. (US) | 2002-06-19 | — | — | EP | disclosed |
| WO-2001017943-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE | TARGACEPT, INC. (US) | 2001-03-15 | — | — | WO | disclosed |
| EP-1042274-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE | R.J. REYNOLDS TOBACCO COMPANY (US) | 2000-10-11 | — | — | EP | disclosed |
| WO-2000023418-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE | R.J. REYNOLDS TOBACCO COMPANY (US) | 2000-04-27 | — | — | WO | disclosed |